1-{5-[4-(5-Ethyl-[1,2,4]oxadiazol-3-yl)-phenoxy]-3-methyl-pentyl}-3-pyridin-4-yl-imidazolidin-2-one

ID: ALA195749

PubChem CID: 5278485

Max Phase: Preclinical

Molecular Formula: C24H29N5O3

Molecular Weight: 435.53

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCc1nc(-c2ccc(OCCC(C)CCN3CCN(c4ccncc4)C3=O)cc2)no1

Standard InChI:  InChI=1S/C24H29N5O3/c1-3-22-26-23(27-32-22)19-4-6-21(7-5-19)31-17-11-18(2)10-14-28-15-16-29(24(28)30)20-8-12-25-13-9-20/h4-9,12-13,18H,3,10-11,14-17H2,1-2H3

Standard InChI Key:  JQPXDPNYNDNAMJ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
    1.0542   -2.6917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7292   -3.4500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0792   -0.2875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0042   -1.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7542   -1.4417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8792   -2.7750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8875   -0.1125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3042   -0.8250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3417   -3.9917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0833   -3.6250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2917   -1.5250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6417   -1.9792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0542   -3.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5917   -2.3625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6875   -3.9792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5667   -1.1125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2917   -2.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8667   -2.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6333   -3.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3250   -4.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8625   -1.5292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5792   -2.7625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3042   -2.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1542   -2.7625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4417   -2.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4375   -3.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1250   -4.5875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2167    0.6458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0167   -2.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7292   -2.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0417    0.7333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0167   -1.5292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  4  1  0
  4 11  1  0
  5  4  2  0
  6  1  1  0
  7  3  2  0
  8  5  1  0
  9  2  1  0
 10  2  1  0
 11 17  2  0
 12  1  2  0
 13  6  1  0
 14  6  1  0
 15 27  1  0
 16 21  2  0
 17 22  1  0
 18 24  1  0
 19 10  2  0
 20 10  1  0
 21 18  1  0
 22 18  2  0
 23 14  1  0
 24 25  1  0
 25 30  1  0
 26 19  1  0
 27 20  2  0
 28  7  1  0
 29 23  1  0
 30 29  1  0
 31 28  1  0
 32 29  1  0
  9 13  1  0
 26 15  2  0
 16 11  1  0
  8  7  1  0
M  END

Associated Targets(non-human)

Enterovirus (1116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Coxsackievirus (559 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rhinovirus A2 (409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterovirus A71 (1246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 435.53Molecular Weight (Monoisotopic): 435.2270AlogP: 4.43#Rotatable Bonds: 10
Polar Surface Area: 84.59Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.48CX LogP: 3.85CX LogD: 3.85
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.47Np Likeness Score: -1.62

References

1. Chang CS, Lin YT, Shih SR, Lee CC, Lee YC, Tai CL, Tseng SN, Chern JH..  (2005)  Design, synthesis, and antipicornavirus activity of 1-[5-(4-arylphenoxy)alkyl]-3-pyridin-4-ylimidazolidin-2-one derivatives.,  48  (10): [PMID:15887961] [10.1021/jm050033v]
2. Egorova A, Ekins S, Schmidtke M, Makarov V..  (2019)  Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.,  178  [PMID:31226653] [10.1016/j.ejmech.2019.06.008]

Source